---
figid: PMC4317900__cas0105-0623-f1
figlink: /pmc/articles/PMC4317900/figure/fig01/
number: Figure 1
caption: Disease-specific mutations in B-cell lymphoid neoplasms. V-raf murine sarcoma
  viral oncogene homolog B (BRAF) is a serine/threonine protein kinase that mediates
  the MAPK pathway. B-cell receptor signaling triggers activation of BRAF. Activated
  BRAF phosphorylates MEKs, which, in turn, leads to activation of ERKs. The V600E
  BRAF mutant in hairy cell leukemia possesses constitutive kinase activity, resulting
  in overactivation of downstream targets. Myeloid differentiation primary-response
  gene 88 (MYD88) is an adaptor protein that plays an essential role in signaling
  by the Toll-like receptors (TLRs) and interleukin-1 receptor (IL-1R). On cell stimulation,
  MYD88 is directly recruited to the Toll/IL-1R (TIR) domain in TLRs/IL-1R, binds
  to Bruton tyrosine kinase (BTK) and acts to recruit IL-1R-associated protein kinases.
  This leads to activation of the nuclear factor-κB (NF-κB) signaling. The L265P MYD88
  mutant in Waldenström macroglobulinemia contributes to constitutive activation of
  the NF-κB signaling by preferential binding to BTK. Inhibitor of DNA binding (ID3)
  is a member of the Id helix–loop–helix proteins, which lack a DNA-binding region
  and function as dominant negative antagonists of basic helix–loop–helix transcription
  factors, including transcription factor 3 (TCF3). TCF3 plays a role in germinal
  center B-cell development and promotes cell growth by activating the B-cell receptor
  signaling pathway, phosphatidylinositol 3-kinase (PI3K) signaling pathway, and positive
  cell cycle regulator cyclin D3 (CCND3). Gain-of-function mutations in TCF3 and loss-of-function
  mutations in ID3, the negative regulator of TCF3, in Burkitt lymphoma enhance the
  TCF3 pathway. NOTCH2 is a single transmembrane receptor. Following NOTCH ligand
  binding, NOTCH receptor is cleaved in the transmembrane region, resulting in the
  release of the intracellular domain (ICD) from the plasma membrane. Then ICD is
  translocated to the nucleus, and activates the transcription of target genes. This
  signal is terminated by phosphorylation (P) of the proline, glutamate, serine, and
  threonine (PEST) domain of the ICD, followed by proteasomal degradation. NOTCH2
  mutants in splenic marginal zone lymphoma lack the degradation signals in the PEST
  domain and act in a gain-of-function manner. AKT, v-akt murine thymoma viral oncogene
  homolog; BCL10, B-cell lymphoma 10; BLNK, B-cell linker; CARD11, caspase recruitment
  domain family, member 11; ECD, extracellular domain; IKK, IκB kinase; IRAK, I interleukin-1
  receptor-associated kinase; MALT1, mucosa associated lymphoid tissue lymphoma translocation
  gene 1; MAML1, mastermind-like 1; MDM2, MDM2 oncogene, E3 ubiquitin protein ligase;
  mTOR, mammalian target of rapamycin; MZB, marginal zone B cell; PLCγ, phospholipase
  C, gamma; PTEN, phosphatase and tensin homolog; RAS, rat sarcoma viral oncogene
  homolog; RASGRP, RAS guanyl releasing protein; RBPJk, recombination signal binding
  protein for immunoglobulin kappa J region; SFK, Src family kinases; SHP1, Src homology
  region 2 domain-containing phosphatase-1; SYK, spleen tyrosine kinase; TAB, TAK1
  binding protein; TAK, TGF beta-activated kinase; TIRAP, TIR adaptor protein; TRAF6,
  TNF receptor-associated factor 6; Ub, ubiquitin.
pmcid: PMC4317900
papertitle: 'Disease-specific mutations in mature lymphoid neoplasms: Recent advances.'
reftext: Mamiko Sakata-Yanagimoto, et al. Cancer Sci. 2014 Jun;105(6):623-629.
pmc_ranked_result_index: '220205'
pathway_score: 0.9687215
filename: cas0105-0623-f1.jpg
figtitle: Disease-specific mutations in B-cell lymphoid neoplasms
year: '2014'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4317900__cas0105-0623-f1.html
  '@type': Dataset
  description: Disease-specific mutations in B-cell lymphoid neoplasms. V-raf murine
    sarcoma viral oncogene homolog B (BRAF) is a serine/threonine protein kinase that
    mediates the MAPK pathway. B-cell receptor signaling triggers activation of BRAF.
    Activated BRAF phosphorylates MEKs, which, in turn, leads to activation of ERKs.
    The V600E BRAF mutant in hairy cell leukemia possesses constitutive kinase activity,
    resulting in overactivation of downstream targets. Myeloid differentiation primary-response
    gene 88 (MYD88) is an adaptor protein that plays an essential role in signaling
    by the Toll-like receptors (TLRs) and interleukin-1 receptor (IL-1R). On cell
    stimulation, MYD88 is directly recruited to the Toll/IL-1R (TIR) domain in TLRs/IL-1R,
    binds to Bruton tyrosine kinase (BTK) and acts to recruit IL-1R-associated protein
    kinases. This leads to activation of the nuclear factor-κB (NF-κB) signaling.
    The L265P MYD88 mutant in Waldenström macroglobulinemia contributes to constitutive
    activation of the NF-κB signaling by preferential binding to BTK. Inhibitor of
    DNA binding (ID3) is a member of the Id helix–loop–helix proteins, which lack
    a DNA-binding region and function as dominant negative antagonists of basic helix–loop–helix
    transcription factors, including transcription factor 3 (TCF3). TCF3 plays a role
    in germinal center B-cell development and promotes cell growth by activating the
    B-cell receptor signaling pathway, phosphatidylinositol 3-kinase (PI3K) signaling
    pathway, and positive cell cycle regulator cyclin D3 (CCND3). Gain-of-function
    mutations in TCF3 and loss-of-function mutations in ID3, the negative regulator
    of TCF3, in Burkitt lymphoma enhance the TCF3 pathway. NOTCH2 is a single transmembrane
    receptor. Following NOTCH ligand binding, NOTCH receptor is cleaved in the transmembrane
    region, resulting in the release of the intracellular domain (ICD) from the plasma
    membrane. Then ICD is translocated to the nucleus, and activates the transcription
    of target genes. This signal is terminated by phosphorylation (P) of the proline,
    glutamate, serine, and threonine (PEST) domain of the ICD, followed by proteasomal
    degradation. NOTCH2 mutants in splenic marginal zone lymphoma lack the degradation
    signals in the PEST domain and act in a gain-of-function manner. AKT, v-akt murine
    thymoma viral oncogene homolog; BCL10, B-cell lymphoma 10; BLNK, B-cell linker;
    CARD11, caspase recruitment domain family, member 11; ECD, extracellular domain;
    IKK, IκB kinase; IRAK, I interleukin-1 receptor-associated kinase; MALT1, mucosa
    associated lymphoid tissue lymphoma translocation gene 1; MAML1, mastermind-like
    1; MDM2, MDM2 oncogene, E3 ubiquitin protein ligase; mTOR, mammalian target of
    rapamycin; MZB, marginal zone B cell; PLCγ, phospholipase C, gamma; PTEN, phosphatase
    and tensin homolog; RAS, rat sarcoma viral oncogene homolog; RASGRP, RAS guanyl
    releasing protein; RBPJk, recombination signal binding protein for immunoglobulin
    kappa J region; SFK, Src family kinases; SHP1, Src homology region 2 domain-containing
    phosphatase-1; SYK, spleen tyrosine kinase; TAB, TAK1 binding protein; TAK, TGF
    beta-activated kinase; TIRAP, TIR adaptor protein; TRAF6, TNF receptor-associated
    factor 6; Ub, ubiquitin.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CARD11
  - MAPK1
  - MAP2K1
  - NFKBIA
  - MAPK12
  - MDM2
  - ID3
  - CHUK
  - IRAK1
  - CCND3
  - IKBKB
  - ECD
  - SYK
  - MAPK3
  - MAPK8
  - MAPK9
  - MAPK10
  - IKBKG
  - TLR10
  - TLR6
  - TLR7
  - TLR8
  - TLR9
  - CD79A
  - MAPK14
  - MTOR
  - MYC
  - MYD88
  - TNFAIP3
  - MAPK13
  - BCL10
  - BLNK
  - BRAF
  - BTK
  - NOTCH4
  - NOTCH2
  - TP53
  - PIK3R5
  - PIK3R4
  - PIK3CA
  - PIK3R6
  - PTEN
  - KRAS
  - HRAS
  - NRAS
  - RASGRP4
  - RASGRP1
  - IRAK4
  - MAPK11
  - RBPJ
  - PTPN6
  - IL1R1
  - TAB1
  - TAB2
  - NR2C2
  - TIRAP
  - AKT1
  - AKT2
  - NOTCH3
  - TLR2
  - TRAF6
  - MAP2K2
  - TLR5
  - AKT3
  - PIK3R3
  - PIK3CB
  - NFKB1
  - RASGRP3
  - PIK3CG
  - TLR3
  - NOTCH1
  - PIK3CD
  - TLR1
  - RASGRP2
  - TLR4
  - Cancer
  - Lung cancer
  - Rheumatoid arthritis
genes:
- word: CARD11
  symbol: CARD11
  source: hgnc_symbol
  hgnc_symbol: CARD11
  entrez: '84433'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: IKBa
  symbol: IkappaBalpha
  source: hgnc_alias_symbol
  hgnc_symbol: NFKBIA
  entrez: '4792'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: MDM2
  symbol: MDM2
  source: hgnc_symbol
  hgnc_symbol: MDM2
  entrez: '4193'
- word: Id3
  symbol: ID3
  source: hgnc_symbol
  hgnc_symbol: ID3
  entrez: '3399'
- word: IKK.
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: CHUK
  entrez: '1147'
- word: IRAK1
  symbol: IRAK1
  source: hgnc_symbol
  hgnc_symbol: IRAK1
  entrez: '3654'
- word: CCND3
  symbol: CCND3
  source: hgnc_symbol
  hgnc_symbol: CCND3
  entrez: '896'
- word: IKK.
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: IKBKB
  entrez: '3551'
- word: ECD
  symbol: ECD
  source: hgnc_symbol
  hgnc_symbol: ECD
  entrez: '11319'
- word: SYK
  symbol: SYK
  source: hgnc_symbol
  hgnc_symbol: SYK
  entrez: '6850'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: IKK.
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: IKBKG
  entrez: '8517'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR10
  entrez: '81793'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR6
  entrez: '10333'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR7
  entrez: '51284'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR8
  entrez: '51311'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR9
  entrez: '54106'
- word: CD79A
  symbol: CD79A
  source: hgnc_symbol
  hgnc_symbol: CD79A
  entrez: '973'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: (MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: Myc
  symbol: MYC
  source: hgnc_symbol
  hgnc_symbol: MYC
  entrez: '4609'
- word: MYD88
  symbol: MYD88
  source: hgnc_symbol
  hgnc_symbol: MYD88
  entrez: '4615'
- word: NEMO
  symbol: NEMO
  source: hgnc_alias_symbol
  hgnc_symbol: IKBKG
  entrez: '8517'
- word: A20
  symbol: A20
  source: hgnc_alias_symbol
  hgnc_symbol: TNFAIP3
  entrez: '7128'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: (BCL10
  symbol: BCL10
  source: hgnc_symbol
  hgnc_symbol: BCL10
  entrez: '8915'
- word: BLNK
  symbol: BLNK
  source: hgnc_symbol
  hgnc_symbol: BLNK
  entrez: '29760'
- word: BRAF
  symbol: BRAF
  source: hgnc_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: BTK
  symbol: BTK
  source: hgnc_symbol
  hgnc_symbol: BTK
  entrez: '695'
- word: Notch
  symbol: Notch
  source: bioentities_symbol
  hgnc_symbol: NOTCH4
  entrez: '4855'
- word: NOTCH2
  symbol: NOTCH2
  source: hgnc_symbol
  hgnc_symbol: NOTCH2
  entrez: '4853'
- word: p53
  symbol: p53
  source: hgnc_alias_symbol
  hgnc_symbol: TP53
  entrez: '7157'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: (PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: RASGRP
  symbol: RASGRP
  source: bioentities_symbol
  hgnc_symbol: RASGRP4
  entrez: '115727'
- word: RASGRP
  symbol: RASGRP
  source: bioentities_symbol
  hgnc_symbol: RASGRP1
  entrez: '10125'
- word: IRAK4
  symbol: IRAK4
  source: hgnc_symbol
  hgnc_symbol: IRAK4
  entrez: '51135'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: RBPJK
  symbol: RBPJK
  source: hgnc_alias_symbol
  hgnc_symbol: RBPJ
  entrez: '3516'
- word: SHP1
  symbol: SHP-1
  source: hgnc_alias_symbol
  hgnc_symbol: PTPN6
  entrez: '5777'
- word: TLR/IL-1R
  symbol: IL1R
  source: hgnc_prev_symbol
  hgnc_symbol: IL1R1
  entrez: '3554'
- word: TAB1
  symbol: TAB1
  source: hgnc_symbol
  hgnc_symbol: TAB1
  entrez: '10454'
- word: TAB2
  symbol: TAB2
  source: hgnc_symbol
  hgnc_symbol: TAB2
  entrez: '23118'
- word: TAK1
  symbol: TAK1
  source: hgnc_alias_symbol
  hgnc_symbol: NR2C2
  entrez: '7182'
- word: (TIRAP
  symbol: TIRAP
  source: hgnc_symbol
  hgnc_symbol: TIRAP
  entrez: '114609'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: Notch
  symbol: Notch
  source: bioentities_symbol
  hgnc_symbol: NOTCH2
  entrez: '4853'
- word: Notch
  symbol: Notch
  source: bioentities_symbol
  hgnc_symbol: NOTCH3
  entrez: '4854'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR2
  entrez: '7097'
- word: TRAF6
  symbol: TRAF6
  source: hgnc_symbol
  hgnc_symbol: TRAF6
  entrez: '7189'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR5
  entrez: '7100'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: NF-KB
  symbol: NF-kappaB
  source: hgnc_alias_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: RASGRP
  symbol: RASGRP
  source: bioentities_symbol
  hgnc_symbol: RASGRP3
  entrez: '25780'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR3
  entrez: '7098'
- word: Notch
  symbol: Notch
  source: bioentities_symbol
  hgnc_symbol: NOTCH1
  entrez: '4851'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR1
  entrez: '7096'
- word: RASGRP
  symbol: RASGRP
  source: bioentities_symbol
  hgnc_symbol: RASGRP2
  entrez: '10235'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR4
  entrez: '7099'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Rheumatoid arthritis
  source: ''
  identifier: ''
---
